These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2825734)

  • 1. Modification of radiosensitivity of bone marrow lymphocytes by WR-2721.
    Naruka K; Bhartiya HC
    Acta Oncol; 1987; 26(4):317-8. PubMed ID: 2825734
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 3. WR-2721 protects against the hematologic toxicity of cyclophosphamide.
    Phillips TL
    J Clin Oncol; 1986 Apr; 4(4):458. PubMed ID: 3007682
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of mouse bone marrow by WR-2721 after fractionated irradiation.
    Travis EL; Fang MZ; Basic I
    Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):377-82. PubMed ID: 2841264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by WR-2721 of human bone marrow function following irradiation.
    Constine LS; Zagars G; Rubin P; Kligerman M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1505-8. PubMed ID: 2428794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the outlook grey for WR-2721 as a clinical radioprotector?
    Denekamp J; Stewart FA; Rojas A
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1247-9. PubMed ID: 6307942
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioprotective effect of WR-2721 (gammaphos) or cystamine in non-uniform lethal gamma irradiated mice.
    Kuna P
    Radiobiol Radiother (Berl); 1986; 27(6):761-9. PubMed ID: 3033737
    [No Abstract]   [Full Text] [Related]  

  • 10. WR-2721: a chemotherapy and radiation-protective agent.
    Schein PS
    Cancer Invest; 1990; 8(2):265-6. PubMed ID: 2169331
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for studies on factors that influence radioprotection of solid tumors by WR-2721.
    Milas L
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):163-5. PubMed ID: 6321410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of the toxicity and radioprotective effect of the chemical radioprotector WR 2721 in dogs (beagles). Part 2: Radioprotective effect of WR 2721 (author's transl)].
    Wagner M; Sedlmeier H; Metzger E; Wustrow T; Messerschmidt O
    Strahlentherapie; 1980 Sep; 156(9):655-62. PubMed ID: 6254212
    [No Abstract]   [Full Text] [Related]  

  • 13. A more general role for WR-2721 in cancer therapy.
    Yuhas JM
    Br J Cancer; 1980 May; 41(5):832-4. PubMed ID: 6252918
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):539-42. PubMed ID: 6286550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray lab.
    Yuhas JM
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):595-8. PubMed ID: 6303993
    [No Abstract]   [Full Text] [Related]  

  • 16. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
    Patchen ML; MacVittie TJ; Jackson WE
    Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK; Walden TL; Hughes HN; Jackson WE
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
    Glover D; Fox KR; Weiler C; Kligerman MM; Turrisi A; Glick JH
    Pharmacol Ther; 1988; 39(1-3):3-7. PubMed ID: 2849130
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotective effect of WR-2721 on haematopoiesis in mice. II. Morphological changes of bone marrow and spleen.
    Macková N; Brezáni P
    Radiobiol Radiother (Berl); 1988; 29(5):595-601. PubMed ID: 2852383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.